Skip to ContentSkip to Navigation
How to find us prof. dr. H.J.M. (Harry) Groen


A Nationwide Study on the Impact of Routine Testing for EGFR Mutations in Advanced NSCLC Reveals Distinct Survival Patterns Based on EGFR Mutation Subclasses

Actionability of on-target ALK resistance mutations in patients with non-small cell lung cancer: local experience and review of the literature

Capmatinib in Patients with METex14-Mutated Non-Small Cell Lung Cancer: GEOMETRY Mono-1 Asian Subgroup Analysis

Clinical Value of EGFR Copy Number Gain Determined by Amplicon-Based Targeted Next Generation Sequencing in Patients with EGFR-Mutated NSCLC

Computed Tomography Screening for Early Lung Cancer, COPD and Cardiovascular Disease in Shanghai: Rationale and Design of a Population-based Comparative Study

Cost-effectiveness of lung cancer screening with low-dose computed tomography in China: A modeling study

Detecting therapy-guiding RNA aberrations in platelets of non-small cell lung cancer patients

Development and Evaluation of a Real-World Outcomes-Based Tool to Support Informed Clinical Decision Making in the Palliative Treatment of Patients With Metastatic NSCLC

Effect of Lowering the Starting Age for Lung Cancer Screening by Low-Dose Computed Tomography Among Women: A Harm-Benefit Analysis

EPAC-lung: European pooled analysis of the prognostic value of circulating tumour cells in small cell lung cancer

Read more


Interview by ZonMw